PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.64%
Positive revenue growth while CSIQ is negative. John Neff might see a notable competitive edge here.
-69.23%
Negative gross profit growth while CSIQ is at 6.43%. Joel Greenblatt would examine cost competitiveness or demand decline.
578.63%
EBIT growth above 1.5x CSIQ's 44.52%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
41.20%
Positive operating income growth while CSIQ is negative. John Neff might view this as a competitive edge in operations.
-149.44%
Negative net income growth while CSIQ stands at 114.96%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-150.00%
Negative EPS growth while CSIQ is at 100.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-150.00%
Negative diluted EPS growth while CSIQ is at 133.33%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.43%
Share count expansion well above CSIQ's 0.20%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.94%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-459.13%
Negative OCF growth while CSIQ is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-402.94%
Negative FCF growth while CSIQ is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
331.84%
10Y revenue/share CAGR under 50% of CSIQ's 8540.94%. Michael Burry would suspect a lasting competitive disadvantage.
331.84%
5Y revenue/share CAGR under 50% of CSIQ's 4467.07%. Michael Burry would suspect a significant competitive gap or product weakness.
73.83%
3Y revenue/share CAGR under 50% of CSIQ's 246.39%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-165.78%
Negative 10Y OCF/share CAGR while CSIQ stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-165.78%
Negative 5Y OCF/share CAGR while CSIQ is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-1141.78%
Negative 3Y OCF/share CAGR while CSIQ stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
81.92%
Below 50% of CSIQ's 462.49%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
81.92%
5Y net income/share CAGR at 50-75% of CSIQ's 115.40%. Martin Whitman might see a shortfall in operational efficiency or brand power.
8.58%
Below 50% of CSIQ's 171.37%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
77.44%
Below 50% of CSIQ's 170.38%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.89%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
5.78%
Inventory growth well above CSIQ's 5.26%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.06%
Asset growth well under 50% of CSIQ's 10.99%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.53%
BV/share growth above 1.5x CSIQ's 1.13%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-12.08%
We’re deleveraging while CSIQ stands at 23.38%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
7.68%
We increase R&D while CSIQ cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
25.74%
SG&A growth well above CSIQ's 37.23%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.